A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Autoimmune Disease

Clinical trial NCT06413511 · WITHDRAWN

Trial details

NCT number: NCT06413511
Sponsor: GlaxoSmithKline
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Autoimmune Diseases

Start date: 2024-06-03
Primary completion: 2025-07-08
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.